In their retrospective series, Sathar et al \[[@ref1]\] concluded that there is significant association between *Helicobacter pylori* infection (*Hp*-I) and portal hypertensive gastropathy (PHG) in cirrhotic patients, also related to PHG severity, thereby necessitating *Hp* eradication.

Apart from PHG, hepatic encephalopathy (HE) is another complication of portal hypertension that remains a major cause of morbidity in cirrhotic patients \[[@ref2]\]. HE encompasses a spectrum of neuropsychiatric disorders related to liver failure and the mechanisms responsible for the neurological alterations in HE begin to emerge \[[@ref3]\].

Hepatitis B (HBV) and C (HCV) infections are among the commonest causes of liver cirrhosis worldwide; *Hp*-I is strongly associated with HBV- and HCV-related cirrhosis in Europe; *Hp*-I is more common in cirrhotic patients with HE than in those without \[[@ref4]\]; HE is not a fully reversible condition and the mechanism behind the lack of reversibility of the neurocognitive status despite the resolution of mental status changes is unclear \[[@ref5]\]; and cognitive dysfunction is a factor associated with falls in cirrhotic patients, though further studies are warranted to address the mechanisms implicated in this predisposition and to design preventive strategies \[[@ref5]\]. In this regard, *Hp*-I has been frequently detected in cognitive impairment and Alzheimer's disease (AD) \[[@ref6]\] and we found that *Hp* eradication may positively influence AD manifestations at five-year clinical endpoints \[[@ref7]\], thereby supporting a role for this common infection in the pathobiology of the disease.

*Hp* may be involved in the pathophysiology of both HE and post-HE persistent cognitive impairment by several mechanisms \[[@ref7]\], including the release of proinflammatory/vasoactive substances, involved, through blood-brain-barrier disruption, in a number of vascular disorders including AD, which can lead to long-term neurologic deficits \[[@ref4],[@ref5]\]. It is therefore important to know if the authors have considered the association between *Hp*-I, HE and/or post-HE cognitive impairment in their cirrhotic patients.
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